Building on the success of its earlier partnership with Eden Park, XCMR has inked a second subcontract for $399,999. This funding will further the development of personal protective respirators that employ human-safe, miniature Far UV-C microplasma lamps.

Following the success of its Phase 1 project, XCMR has been awarded a $784,502 Phase 2 AFWERX award by the Department of Defense. This funding will further support the development of XCMR’s next-generation personal protective equipment (PPE) for real-time inactivation of airborne biological threats.

“With technology constantly changing, we need innovation and cutting-edge technology to keep up with the demands that we find ourselves thrust in from the pandemic,” EPA Mid-Atlantic Regional Administrator Adam Ortiz. “XCMR is helping in this fight with their skills and know-how, which complements our mission of protecting human health and the environment.”

XCMR has received a $99,771 Phase 1 SBIR award from the Environmental Protection Agency (EPA) to support its development of Far UV-C technology for decontamination and infection control.

XCMR has been awarded a $49,974 Phase 1 AFWERX award by the Department of Defense (DoD) to develop next-generation personal protective equipment (PPE) for real-time inactivation of airborne biological threats.